Listen as Ira M. Jacobson, MD; Paul Y. Kwo, MD; and Tatyana Kushner, MD, MSCE, discuss the role of quantitative HBsAg testing in current clinical practice and where it may play a role in the future.
Should quantitative HBsAg testing be used routinely in clinical practice for patients living with chronic hepatitis B?
In this episode, Tatyana Kushner, MD, MSCE, discusses the role of quantitative hepatitis B surface antigen testing in people living with chronic hepatitis B, including:
Joining her for the panel discussion are Ira M. Jacobson, MD, and Paul Y. Kwo, MD.
Presenters:
Ira M. Jacobson, MD
Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York
Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at
Mount Sinai
New York, New York
Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California
Link to the full program:
https://bit.ly/3R1PMi4
Link to the slides:
https://bit.ly/3N5Fpsm